These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17698234)

  • 21. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.
    Osborn BL; Olsen HS; Nardelli B; Murray JH; Zhou JX; Garcia A; Moody G; Zaritskaya LS; Sung C
    J Pharmacol Exp Ther; 2002 Nov; 303(2):540-8. PubMed ID: 12388634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification, and lipolytic activity of recombinant human serum albumin fusion proteins with one domain of human growth hormone in Pichia pastoris.
    Wang F; Wu M; Liu W; Shen Q; Sun H; Chen S
    Biotechnol Appl Biochem; 2013; 60(4):405-11. PubMed ID: 23750891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a high performance size exclusion chromatography method to determine the stability of Human Serum Albumin in a lyophilized formulation of Interferon alfa-2b.
    Qian J; Tang Q; Cronin B; Markovich R; Rustum A
    J Chromatogr A; 2008 Jun; 1194(1):48-56. PubMed ID: 18258245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of albumin fusion patterns on the production and bioactivity of the somatostatin-14 fusion protein in Pichia pastoris.
    Ding Y; Fan J; Li W; Yang R; Peng Y; Deng L; Wu Y; Fu Q
    Appl Biochem Biotechnol; 2013 Aug; 170(7):1637-48. PubMed ID: 23712794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intact bioactivities and improved pharmacokinetic of the SL335-IFN-β-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-β.
    Ji SI; Park JH; You HG; Chi HJ; Bang YW; Cha SH
    Immunol Lett; 2019 Mar; 207():46-55. PubMed ID: 30684504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to maximize expression of rightly processed human interferon alpha2b in Pichia pastoris.
    Salunkhe S; Soorapaneni S; Prasad KS; Raiker VA; Padmanabhan S
    Protein Expr Purif; 2010 Jun; 71(2):139-46. PubMed ID: 20159042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous Purification of Human Interferon Alpha-2b and Serum Albumin Using Bioprivileged Fluorinated Ionic Liquid-Based Aqueous Biphasic Systems.
    Carvalho SF; Pereiro AB; Araújo JMM
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A novel recombinant human interferon alpha2b with high antivirus activity by combinatorial mutagenesis].
    Zhao G; Du L; Zhu L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):347-51. PubMed ID: 21604500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonist peptides of human interferon-alpha2b isolated from phage display library inhibit interferon induced antiviral activity.
    Tian W; Bai G; Li ZH; Yang WB
    Acta Pharmacol Sin; 2006 Aug; 27(8):1044-50. PubMed ID: 16867257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.
    Yanai Y; Sanou O; Kayano T; Ariyasu H; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
    J Interferon Cytokine Res; 2001 Oct; 21(10):835-41. PubMed ID: 11710996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and biologic characterization of recombinant interferon-alpha2b.
    Bordens R; Grossberg SE; Trotta PP; Nagabhushan TL
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-41-S9-51. PubMed ID: 9208872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection.
    Jones TD; Hanlon M; Smith BJ; Heise CT; Nayee PD; Sanders DA; Hamilton A; Sweet C; Unitt E; Alexander G; Lo KM; Gillies SD; Carr FJ; Baker MP
    J Interferon Cytokine Res; 2004 Sep; 24(9):560-72. PubMed ID: 15450132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some factors affecting the stability of interferon alpha 2b in solution.
    Ruiz L; Reyes N; Aroche K; Báez R; Aldana R; Hardy E
    Biologicals; 2006 Mar; 34(1):15-9. PubMed ID: 16188456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel glycosylated human interferon alpha 2b expressed in glycoengineered Pichia pastoris and its biological activity: N-linked glycoengineering approach.
    Katla S; Yoganand KNR; Hingane S; Ranjith Kumar CT; Anand B; Sivaprakasam S
    Enzyme Microb Technol; 2019 Sep; 128():49-58. PubMed ID: 31186110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells.
    Brassard DL; Delorenzo MM; Cox S; Leaman DW; Sun Y; Ding W; Gavor S; Spond J; Goodsaid F; Bordens R; Grace MJ
    J Interferon Cytokine Res; 2004 Aug; 24(8):455-69. PubMed ID: 15320959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of HPLC/MS analysis with a multi-enzyme digest strategy to characterize different interferon product variants produced from Pichia pastoris.
    Wang Y; Liu D; Crowell LE; Love KR; Wu SL; Hancock WS
    Amino Acids; 2019 Sep; 51(9):1353-1363. PubMed ID: 31446487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of next generation of therapeutic IFN-α2b via genetic code expansion.
    Zhang B; Xu H; Chen J; Zheng Y; Wu Y; Si L; Wu L; Zhang C; Xia G; Zhang L; Zhou D
    Acta Biomater; 2015 Jun; 19():100-11. PubMed ID: 25769229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological properties of chimeric interferon-alpha2b peptides.
    Peña C; Blank VC; Marino VJ; Roguin LP
    Peptides; 2005 Jul; 26(7):1144-9. PubMed ID: 15949632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.
    Braun A; Alsenz J
    Pharm Res; 1997 Oct; 14(10):1394-400. PubMed ID: 9358552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Pharmacokinetics, Tissue Distribution, Excretion of Recombinant Liver-Targeting Interferon with IFN α2b Administered Intramuscular in Rats.
    Wang J; Lu X; Jin X; Zeng W; Zhu J
    Curr Pharm Biotechnol; 2015; 16(10):911-9. PubMed ID: 26278706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.